Conflict of interest: The authors involved in each clinical trial were excluded from being members of the committee for judging the level of evidence and the recommendation for the respective clinical trial.
Guidelines for the diagnosis and treatment of vitiligo in Japan
Article first published online: 27 FEB 2013
© 2013 Japanese Dermatological Association
The Journal of Dermatology
Special Issue: Special Issue: Genetics of hypopigmentary disorders (pages 309-356)
Volume 40, Issue 5, pages 344–354, May 2013
How to Cite
Oiso, N., Suzuki, T., Wataya-kaneda, M., Tanemura, A., Tanioka, M., Fujimoto, T., Fukai, K., Kawakami, T., Tsukamoto, K., Yamaguchi, Y., Sano, S., Mitsuhashi, Y., Nishigori, C., Morita, A., Nakagawa, H., Mizoguchi, M. and Katayama, I. (2013), Guidelines for the diagnosis and treatment of vitiligo in Japan. The Journal of Dermatology, 40: 344–354. doi: 10.1111/1346-8138.12099
- Issue published online: 14 MAY 2013
- Article first published online: 27 FEB 2013
- Manuscript Accepted: 20 DEC 2012
- Manuscript Received: 19 DEC 2012
- for Research for Incurable Disorders from the Ministry of Health, Welfare and Labor of Japan. Grant Numbers: 21210901, o. 22141101
- vitamin D3 analogs;
Vitiligo is an acquired pigment disorder in which depigmented macules result from the loss of melanocytes from the involved regions of skin and hair. The color dissimilarity on the cosmetically sensitive regions frequently induces quality of life impairment and high willingness to pay for treatment in patients with vitiligo. The Vitiligo Japanese Task Force was organized to overcome this situation and to cooperate with the Vitiligo Global Issues Consensus Conference. This guideline for the diagnosis and treatment of vitiligo in Japan is proposed to improve the circumstances of Japanese individuals with vitiligo. Its contents include information regarding the diagnosis, pathogenesis, evaluation of disease severity and effectiveness of treatment, and evidence-based recommendations for the treatment of vitiligo. The therapeutic algorithm based on the proposed recommendation is designed to cure and improve the affected lesions and quality of life of individuals with vitiligo.